Drug recall · April 28, 2021
Estradiol Transdermal System Delivers 0.0375 mg/day recall
Why: Defective Delivery System: Out of specification for release rate testing and shear, an attribute related to the adhesive properties of the transdermal patches. As a result, patients could experience patches that do not stick well to the skin.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Estradiol Transdermal System Delivers 0.0375 mg/day, 8 Systems/box, Rx only, Mfd. by: Noven Pharmaceuticals, Inc. Miami, Florida 33186 Dist. by: Noven Therapeutics, LLC Miami, Florida 33186, NDC 68968-3437-8
- Lots / codes
Lot #: 88321 Exp. 02/2022
- Quantity
- 10872 cartons
- Company
- Noven Pharmaceuticals Inc, Miami, FL
- Distribution
- Nationwide within the United States
- Initiated
- April 16, 2021 · Voluntary: Firm initiated
- Classified
- April 20, 2021
- Reported
- April 28, 2021
- Ended
- October 11, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Estradiol
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.